ORKA FY 2016 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$24,000

Operating Income

-$17M

Net Income

-$16M

EPS (Diluted)

$-390.96

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$25M

Total Liabilities

$2M

Stockholders' Equity

$22M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$24,000	-$19,000	-26.3%
Operating Income	-$17M	-$11M	-45.0%
Net Income	-$16M	-$11M	-43.7%